Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

Pujade-Lauraine, E; Selle, F; Scambia, G; Asselain, B; Marmé, F; Lindemann, K; Colombo, N; Madry, R; Glasspool, R; Vergote, I; Korach, J; Lheureux, S; Dubot, C; Oaknin, A; Zamagni, C; Heitz, F; Gladieff, L; Rubio-Pérez, M J; Scollo, P; Blakeley, C; Shaw, B; Ray-Coquard, I; Redondo, A.

Ann Oncol ; 34(12): 1152-1164, 2023 12.

Artículo en Inglés | MEDLINE | ID: mdl-37797734

2.

OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer.

Frangou, E; Bertelli, G; Love, S; Mackean, M J; Glasspool, R M; Fotopoulou, C; Cook, A; Nicum, S; Lord, R; Ferguson, M; Roux, R L; Martinez, M; Butcher, C; Hulbert-Williams, N; Howells, L; Blagden, S P.

Gynecol Oncol ; 162(2): 431-439, 2021 08.

Artículo en Inglés | MEDLINE | ID: mdl-34059348

3.

A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.

Hall, M R; Dehbi, H-M; Banerjee, S; Lord, R; Clamp, A; Ledermann, J A; Nicum, S; Lilleywhite, R; Bowen, R; Michael, A; Feeney, A; Glasspool, R; Hackshaw, A; Rustin, G.

Gynecol Oncol ; 159(3): 692-698, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-33077258

4.

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Goranova, T; Ennis, D; Piskorz, A M; Macintyre, G; Lewsley, L A; Stobo, J; Wilson, C; Kay, D; Glasspool, R M; Lockley, M; Brockbank, E; Montes, A; Walther, A; Sundar, S; Edmondson, R; Hall, G D; Clamp, A; Gourley, C; Hall, M; Fotopoulou, C; Gabra, H; Freeman, S; Moore, L; Jimenez-Linan, M; Paul, J; Brenton, J D; McNeish, I A.

Br J Cancer ; 120(8): 868, 2019 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-30862952

5.

Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real-life experience.

Rust, K; Spiliopoulou, P; Tang, C Y; Bell, C; Stirling, D; Phang, Thf; Davidson, R; Mackean, M; Nussey, F; Glasspool, R M; Reed, N S; Sadozye, A; Porteous, M; McGoldrick, T; Ferguson, M; Miedzybrodzka, Z; McNeish, I A; Gourley, C.

BJOG ; 125(11): 1451-1458, 2018 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-29460478

6.

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Goranova, T; Ennis, D; Piskorz, A M; Macintyre, G; Lewsley, L A; Stobo, J; Wilson, C; Kay, D; Glasspool, R M; Lockley, M; Brockbank, E; Montes, A; Walther, A; Sundar, S; Edmondson, R; Hall, G D; Clamp, A; Gourley, C; Hall, M; Fotopoulou, C; Gabra, H; Freeman, S; Moore, L; Jimenez-Linan, M; Paul, J; Brenton, J D; McNeish, I A.

Br J Cancer ; 116(10): 1294-1301, 2017 May 09.

Artículo en Inglés | MEDLINE | ID: mdl-28359078

7.

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours.

Leary, A F; Quinn, M; Fujiwara, K; Coleman, R L; Kohn, E; Sugiyama, T; Glasspool, R; Ray-Coquard, I; Colombo, N; Bacon, M; Zeimet, A; Westermann, A; Gomez-Garcia, E; Provencher, D; Welch, S; Small, W; Millan, D; Okamoto, A; Stuart, G; Ochiai, K.

Ann Oncol ; 28(4): 718-726, 2017 04 01.

Artículo en Inglés | MEDLINE | ID: mdl-27993794

8.

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer.

Glasspool, R M; Brown, R; Gore, M E; Rustin, G J S; McNeish, I A; Wilson, R H; Pledge, S; Paul, J; Mackean, M; Hall, G D; Gabra, H; Halford, S E R; Walker, J; Appleton, K; Ullah, R; Kaye, S.

Br J Cancer ; 110(8): 1923-9, 2014 Apr 15.

Artículo en Inglés | MEDLINE | ID: mdl-24642620

9.

Microfluidic technologies for immunotherapy studies on solid tumours.

Paterson, K; Zanivan, S; Glasspool, R; Coffelt, S B; Zagnoni, M.

Lab Chip ; 21(12): 2306-2329, 2021 06 15.

Artículo en Inglés | MEDLINE | ID: mdl-34085677

10.

Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial.

Barrett, S V; Paul, J; Hay, A; Vasey, P A; Kaye, S B; Glasspool, R M.

Ann Oncol ; 19(5): 898-902, 2008 May.

Artículo en Inglés | MEDLINE | ID: mdl-18272913

11.

Letter comments on: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.

Cartwright, D; White, M; Crearie, C; Forte, C; Coulter, S; Brown, J; Randhawa, M; Glasspool, R; Roxburgh, P.

ESMO Open ; 7(4): 100533, 2022 08.

Artículo en Inglés | MEDLINE | ID: mdl-35870374

12.

Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.

Plumb, J A; Bilsland, A; Kakani, R; Zhao, J; Glasspool, R M; Knox, R J; Evans, T R; Keith, W N.

Oncogene ; 20(53): 7797-803, 2001 Nov 22.

Artículo en Inglés | MEDLINE | ID: mdl-11753658

13.

Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.

Zhao, J Q; Glasspool, R M; Hoare, S F; Bilsland, A; Szatmari, I; Keith, W N.

Neoplasia ; 2(6): 531-9, 2000.

Artículo en Inglés | MEDLINE | ID: mdl-11228546

14.

Clinical imaging of cancer metastasis.

Glasspool, R M; Evans, T R.

Eur J Cancer ; 36(13 Spec No): 1661-70, 2000 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-10959052

15.

Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancer.

Glasspool, R M; Twelves, C J.

Breast ; 10(5): 368-78, 2001 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-14965609

16.

Clinical significance of transient hyperthyroidism in the course of non-Hodgkin's lymphoma.

Glasspool, R M; Vasey, P A; Peden, N.

Clin Oncol (R Coll Radiol) ; 13(4): 309-10, 2001.

Artículo en Inglés | MEDLINE | ID: mdl-11554634

17.

Epigenetics as a mechanism driving polygenic clinical drug resistance.

Glasspool, R M; Teodoridis, J M; Brown, R.

Br J Cancer ; 94(8): 1087-92, 2006 Apr 24.

Artículo en Inglés | MEDLINE | ID: mdl-16495912

18.

Telomerase and cancer: time to move from a promising target to a clinical reality.

Keith, W N; Jeffry Evans, T R; Glasspool, R M.

J Pathol ; 195(4): 404-14, 2001 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-11745671

19.

A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.

Mackay, H J; Hill, M; Twelves, C; Glasspool, R; Price, T; Campbell, S; Massey, A; Macham, M A; Uzzel, M; Bailey, S M; Martin, C; Cunningham, D.

Ann Oncol ; 14(8): 1264-9, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12881390

20.

Epigenetic modulation of resistance to chemotherapy?

Brown, R; Glasspool, R.

Ann Oncol ; 18(9): 1429-30, 2007 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-17761701

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: